| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Sodium bicarbonate 600 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Magnesium carbonate compound tablet (product) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Atropine sulfate 600 microgram oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Magnesium trisilicate+belladonna 0.15mg tablet (product) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Dicycloverine hydrochloride 20 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Dicycloverine hydrochloride 10 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Hyoscine butylbromide 10 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Propantheline bromide 15 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Mebeverine hydrochloride 100 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Mebeverine hydrochloride 135 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Cimetidine 400 mg effervescent oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Cimetidine 200 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Cimetidine 400 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Cimetidine 800 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Ranitidine (as ranitidine hydrochloride) 300 mg effervescent oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Product containing precisely ranitidine (as ranitidine hydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Tripotassium dicitratobismuthate 120 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Product containing precisely sucralfate 1 gram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Famotidine 20 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Famotidine 40 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Product containing precisely misoprostol 200 microgram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Omeprazole 10 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Omeprazole 20 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Omeprazole 40 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Ranitidine bismuth citrate 400 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Pantoprazole (as pantoprazole sodium sesquihydrate) 40 mg gastro-resistant oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Pantoprazole (as pantoprazole sodium sesquihydrate) 20 mg gastro-resistant oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Product containing precisely rabeprazole sodium 10 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Product containing precisely rabeprazole sodium 20 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Clarithromycin 500mg tablet and lansoprazole 30mg capsule and amoxycillin 500mg capsule pack (product) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Esomeprazole 40 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Esomeprazole 20 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Co-phenotrope 2500mcg/25micrograms tablet (product) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Loperamide hydrochloride 2 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Product containing precisely mesalazine 250 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Mesalazine 500mg m/r tablet (product) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Mesalazine 400 mg gastro-resistant oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Sulfasalazine 500 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Olsalazine sodium 500 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Methylcellulose-450 500 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Product containing precisely bisacodyl 5 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Senna 7.5 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Ursodeoxycholic acid 300 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Ursodeoxycholic acid 150 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Pancreatin e/c tablet (product) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Urea[13C] 100mg soluble tablet (product) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Product containing precisely digoxin 62.5 microgram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Digoxin 125 microgram oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Digoxin 250 microgram oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Digitoxin 100 microgram oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Bendroflumethiazide 2.5 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Bendroflumethiazide 5 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Chlortalidone 50 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Product containing precisely cyclopenthiazide 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Indapamide 1.5mg m/r tablet (product) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Indapamide 2.5 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Metolazone 5 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Polythiazide 1 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Xipamide 20 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Product containing precisely furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Furosemide 500 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Bumetanide 1 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Bumetanide 5 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Torasemide 2.5 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Torasemide 5 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Torasemide 10 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Amiloride hydrochloride 5 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Spironolactone 25 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Spironolactone 50 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Spironolactone 100 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Co-triamterzide 50mg/25mg tablet (product) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Amiloride hydrochloride 2.5 mg and cyclopenthiazide 250 microgram oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Amiloride hydrochloride 5 mg and bumetanide 1 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Amiloride hydrochloride 2.5 mg and hydrochlorothiazide 25 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| clorhidrato de amilorida+hidroclorotiazida, 5 mg/50 mg, comprimido |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Hydroflumethiazide 25 mg and spironolactone 25 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Amiloride hydrochloride 10 mg and furosemide 80 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| bumetanida+potasio 500 mcg/7,7 mmol, comprimido de liberación modificada |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| bendrofluazida+potasio, 2,5 mg/7,7 mmol, comprimido de liberación modificada (producto) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| furosemida+potasio 40 mg/8 mmol, comprimido de liberación modificada |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| furosemida+potasio, 20 mg/10 mmol, comprimido de liberación modificada |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| bendrofluazida+potasio, 2,5 mg/8,4 mmol, comprimido de liberación modificada |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Felodipine 2.5 mg and ramipril 2.5 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Felodipine 5 mg and ramipril 5 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Amiodarone hydrochloride 100 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Amiodarone hydrochloride 200 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Verapamil hydrochloride 40 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Verapamil hydrochloride 80 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Verapamil hydrochloride 120 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Verapamil hydrochloride 240mg m/r tablet (product) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Verapamil hydrochloride 120mg m/r tablet (product) |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|
| Verapamil hydrochloride 160 mg oral tablet |
Has manufactured dose form |
False |
Tablet |
relación inferida |
restricción existencial (metadato del núcleo) |
|